Works matching IS 14642662 AND DT 2005 AND VI 6 AND IP 2

Results: 13

Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naïve cohort.

Published in:

2005

By:

El-Sadr WM;
Mullin CM;
Carr A;
Gibert C;
Rappoport C;
Visnegarwala F;
Grunfeld C;
Raghavan SS

Publication type:

Journal Article

There and back again: the impact of adult HIV prevalence on national life expectancies.

Published in:

2005

By:

McGuire, A. L.;
Barer, J. M.;
Montaner, J. S. G.;
Hogg, R. S.

Publication type:

Letter

Ethnic differences in stage of presentation of adults newly diagnosed with HIV-1 infection in south London.

Published in:

HIV Medicine, 2005, v. 6, n. 2, p. 59, doi. 10.1111/j.1468-1293.2005.00267.x

By:

Boyd, A. E;
Murad, S.;
O'Shea, S.;
de Ruiter, A.;
Watson, C.;
Easterbrook, P. J.

Publication type:

Article

Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection.

Published in:

HIV Medicine, 2005, v. 6, n. 2, p. 66, doi. 10.1111/j.1468-1293.2005.00268.x

By:

Torre, D.;
Speranza, F.;
Martegani, R.

Publication type:

Article

Patient characteristics and costs associated with dyslipidaemia and related conditions in HIV-infected patients: a retrospective cohort study.

Published in:

HIV Medicine, 2005, v. 6, n. 2, p. 79, doi. 10.1111/j.1468-1293.2005.00269.x

By:

Richter, A.;
Pladevall, M.;
Manjunath, R.;
Lafata, J. E.;
Xi, H.;
Simpkins, J.;
Brar, I.;
Markowitz, N.;
Iloeje, U.H.;
Irish, W.

Publication type:

Article

Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapy.

Published in:

HIV Medicine, 2005, v. 6, n. 2, p. 91, doi. 10.1111/j.1468-1293.2005.00270.x

By:

Andersen, O.;
Haugaard, S. B.;
Holst, J. J.;
Deacon, C. F.;
Iversen, J.;
Andersen, U. B.;
Nielsen, J. O.;
Madsbad, S.

Publication type:

Article

Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.

Published in:

HIV Medicine, 2005, v. 6, n. 2, p. 99, doi. 10.1111/j.1468-1293.2005.00271.x

By:

Krentz, H. B.;
Kliewer, G.;
Gill, M.J.

Publication type:

Article

Comparison of gastrointestinal tolerability and patient preference for treatment with the 625 mg and 250 mg nelfinavir tablet formulations.

Published in:

HIV Medicine, 2005, v. 6, n. 2, p. 107, doi. 10.1111/j.1468-1293.2005.00272.x

By:

Johnson, M.;
Nieto-Cisneros, L.;
Horban, A.;
Arasteh, K.;
Gonzalez-Garcia, J.;
Artigas, J. G.;
Clotet, B.;
Danise, A.;
Landman, R.;
Proll, S.;
Snowden, W.;
Foreman, R.;
Smith, P.

Publication type:

Article

Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naïve cohort.

Published in:

HIV Medicine, 2005, v. 6, n. 2, p. 114, doi. 10.1111/j.1468-1293.2005.00273.x

By:

El-Sadr, W. M.;
Mullin, C. M.;
Carr, A.;
Gibert, C.;
Rappoport, C.;
Visnegarwala, F.;
Grunfeld, C.;
Raghavan, S. S.

Publication type:

Article

The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy.

Published in:

HIV Medicine, 2005, v. 6, n. 2, p. 122, doi. 10.1111/j.1468-1293.2005.00274.x

By:

Cardiello, P.;
Srasuebkul, P.;
Hassink, E.;
Mahanontharit, A.;
Samor, T.;
Ruxrungtham, K.;
Lange, J.;
Cooper, D.;
Phanuphak, P.

Publication type:

Article

Factors associated with virological response in HIV-infected patients failing antiretroviral therapy: a prospective cohort study.

Published in:

HIV Medicine, 2005, v. 6, n. 2, p. 129, doi. 10.1111/j.1468-1293.2005.00275.x

By:

Fournier, S.;
Chaffaut, C.;
Maillard, A.;
Loze, B.;
Lascoux, C.;
Gérard, L.;
Timsit, J.;
David, F.;
Bergmann, J.-F.;
Oksenhendler, E.;
Sereni, D.;
Chevret, S.;
Molina, J.-M.

Publication type:

Article

Mitochondrial DNA depletion in liver tissue of patients infected with hepatitis C virus: contributing effect of HIV infection?

Published in:

HIV Medicine, 2005, v. 6, n. 2, p. 135, doi. 10.1111/j.1468-1293.2005.00276.x

By:

Bäuerle, J.;
Laguno, M.;
Mauss, S.;
Mallolas, J.;
Murillas, J.;
Miquel, R.;
Schmutz, G.;
Setzer, B.;
Gatell, J. M.;
Walker, U. A.

Publication type:

Article

The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy.

Published in:

HIV Medicine, 2005, v. 6, n. 2, p. 140, doi. 10.1111/j.1468-1293.2005.00277.x

By:

Jevtović, D. J.;
Salemović, D.;
Ranin, J.;
Pes&icaron;ć, I.;
Žerjav, S.;
Djurković-Djaković, O.

Publication type:

Article